Exemplis Discimus 2001, 145(2):75-76

Phasellus tempor rhoncus pede.

Kayda Solomona, Charratha Reyesb, Drea Reu Laic, Arten Ashukahwaa, Tel Shenuria
a Faculty of Radiology, University Hospital of Moddell, Republic of Tund
b 2nd Clinic of Dermatology, Teaching Hospital of Falleen, Iego Republic
c National Institute of Speech Therapy, Endor Faculty Hospital, Republic of Sullust

Suspendisse nisi risus, tempor id, gravida nec, volutpat nec, dui. Morbi tortor est, placerat ac, commodo vel, ultricies ac, urna. Aliquam sed nisi id lacus faucibus porttitor. Morbi eu augue sit amet lectus venenatis blandit. Phasellus nisi metus, scelerisque eu, mollis vitae, convallis vitae, massa.. Integer pede magna, dictum quis, pulvinar ac, elementum sodales, metus. Aenean tellus ipsum, congue eget, elementum ut, ultrices id, nisl. Mauris orci odio, gravida sed, laoreet in, pulvinar vel, dui.

Klíčová slova: Morbi facilisis, Nullam sit amet eros, Fusce id metus

Vloženo: 10. leden 2002; Zveřejněno: 1. prosinec 2001 

Zobrazit celý článek

Reference

  1. Shalhoub, V., Faust, J., Boyle, W. J. et al. (1999) Osteoprotegerin and osteoprotegerin ligand effects on osteoclasts formation from human peripheral blood mononuclear cell precursors. J. Cell. Biochem. 72, 251-261. Přejít k původnímu zdroji... Přejít na PubMed...
  2. Browner, W. B., Li-Yang, L., Cummingsa, S. R. (2001) Associations of Serum Osteoprotegerin Levels With Diabetes, Stroke, Bone density, fractures and mortality in Elderly Women. The J of Clin. Endocrinology and Metabolism 86, 631-637. Přejít k původnímu zdroji...
  3. Yano, K., Shibata, O., Mizuno, A., Kobayashi, F., Higashio, K., Morinaga, T., Tsuda, E. et al. (2001) Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (opg/ocif): possible role of opg/ocif in the prevention of osteoporosis in pregnancy. Biochem. Biophys. Res. Commun. 288, 217-224. Přejít k původnímu zdroji... Přejít na PubMed...

Zpět na obsah